6-Shogaol, a potent bioactive compound in ginger (Zingiber officinale Roscoe), has been reported for anti-inflammatory and anti-
cancer activity. In this study, we investigated the effect of
6-shogaol to enhance
tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL)-mediated apoptosis. The combined treatment with
6-shogaol and TRAIL markedly induces apoptosis in various
cancer cells (
renal carcinoma Caki cells,
breast carcinoma MDA-MB-231 cells and
glioma U118MG cells), but not in normal mesangial cells and normal mouse kidney cells.
6-Shogaol reduced the mitochondrial membrane potential (
MMP) and released
cytochrome c from mitochondria to cytosol via Bax activation. Furthermore, we found that
6-shogaol induced down-regulation of c-
FLIP(L) expression at the post-translational levels and the overexpression of c-
FLIP(L) markedly inhibited
6-shogaol plus TRAIL-induced apoptosis. Moreover,
6-shogaol increased
reactive oxygen species (ROS) production in Caki cells. Pretreatment with ROS scavengers attenuated
6-shogaol plus TRAIL-induced apoptosis through inhibition of
MMP reduction and down-regulation of c-
FLIP(L) expression. In addition,
6-gingerol, another phenolic alkanone isolated from ginger, did not enhance TRAIL-induced apoptosis and down-regulate c-
FLIP(L) expression. Taken together, our results demonstrated that
6-shogaol enhances TRAIL-mediated apoptosis in
renal carcinoma Caki cells via ROS-mediated
cytochrome c release and down-regulation of c-
FLIP(L) expression.